SITRAN at night lit up

Sheffield Institute for Translational Neuroscience

SITraN is an essential development in the fight against motor neurone disease, other common neurodegenerative disorders, stroke and neuroinflammatory conditions.

Photo of Queen Elizabeth II visiting SITraN in 2010
Photo of Queen Elizabeth II visiting SITraN in 2010
About SITraN 
Scientist taking notes in SITraN
Our impact 
SITraN facilities
Our research 
Neuroscience facilities
Study with us 
The exterior of the SITraN building at the University of Sheffield
Facilities 

News

Dementia patient

New clue in understanding increased Alzheimer’s risk

Scientists have discovered a new piece of the puzzle in understanding why some people are more susceptible to Alzheimer’s disease.
Pam Shaw in front of SITraN

Comment: A devastating setback for MND research: Why NICE needs to reconsider its approach to tofersen

Professor Dame Pamela Shaw, Director of the Sheffield Institute for Translational Neuroscience, discusses NICE's refusal to classify the MND drug tofersen, as a treatment for a highly specialised condition, rather than just a standard drug.
Image of motor neurones

Sheffield team is sole UK recipient to be awarded share of $5 million global funding to fight motor neuron disease

A team of researchers from the University of Sheffield have been awarded a share of a prestigious grant to fight MND.
A young MND patient being cared for by their mum

New psychological therapy shows promise in improving quality of life for people living with MND

Therapy can significantly improve quality of life for people living with MND when delivered alongside usual care, a pioneering study led by the University of Sheffield has shown.
SITRAN at night lit up